Neil R. Smith

AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer

Stephen R. Wedge, Jane Kendrew, Laurent Hennequin et al. · Cancer Research · 2005 · 711 citations · Full text

Medicine, Oncology, Pharmacology +17

A No-Prophylaxis Platelet-Transfusion Strategy for Hematologic Cancers

Simon Stanworth, Lise J Estcourt, Gillian Powter et al. · New England Journal of Medicine · 2013 · 468 citations

Medicine, Hematology, Oncology +17

Longitudinal Associations Between Cyberbullying Involvement and Adolescent Mental Health

Amanda Fahy, Stephen Stansfeld, Melanie Smuk et al. · Journal of Adolescent Health · 2016 · 450 citations · Full text

Social Sciences, Psychology, Social Psychology +14

DNA from Buccal Swabs Recruited by Mail: Evaluation of Storage Effects on Long-Term Stability and Suitability for Multiplex Polymerase Chain Reaction Genotyping

Bernard Freeman, Neil R. Smith, Charles Curtis et al. · Behavior Genetics · 2003 · 306 citations

Life Sciences, Genetics, Molecular Genetics +16

High-Level Clonal <i>FGFR</i> Amplification and Response to FGFR Inhibition in a Translational Clinical Trial

Alex Pearson, Elizabeth Smyth, Irina S. Babina et al. · Cancer Discovery · 2016 · 276 citations · Full text

Medicine, Cancer Biology, Oncology +17